This trial will investigate the effect of lorcaserin on the brain's control of appetite and metabolism.
1 Primary · 2 Secondary · Reporting Duration: 6 months
Active Control
Non-Treatment Group
40 Total Participants · 2 Treatment Groups
Primary Treatment: Active · Has Placebo Group · Phase 4
Age 18 - 65 · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: